XML 43 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Details-4) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Beginning balance, $ (49,349) $ (66,856) $ (64,628) $ (72,346)
Realized and unrealized gains (losses):        
Included in regulatory liabilities (assets) (3,752) (1,472) 11,528 4,018
Included in other comprehensive income 0 0 0 0
Included in earnings (1,419) (174) 5,837 (2,034)
Included in current assets 0 (38) (89) (94)
Purchases 6,371 6,052 19,900 17,709
Sales 0 0 (60) (2)
Issuances 0 0 0 0
Settlements (4,952) (5,840) (25,589) (15,579)
Transfers in and/or out of level 3 0 0 0 0
Ending balance, (53,101) (68,328) (53,101) (68,328)
Total gains (losses) included in earnings attributed to the change in unrealized gains (losses) related to assets and liabilities 0 [1] 0 [1] 0 [1] 0 [1]
Purchased Power Expense [Member]
       
Realized and unrealized gains (losses):        
Included in earnings (1,411) [1] (174) [1] 5,845 [1] (2,034) [1]
Cost Of Gas Sold Expense [Member]
       
Realized and unrealized gains (losses):        
Included in earnings $ (8) [1] $ 0 [1] $ (8) [1] $ 0 [1]
[1]

MGE's exchange-traded derivative contracts, over-the-counter party transactions, ten-year purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.